Atea Pharmaceuticals(AVIR)
BOSTON, MA
PharmaceuticalFocus: Nucleoside and nucleotide analogs to inhibit the viral RNA polymerase
Atea Pharmaceuticals is a life sciences company focused on Nucleoside and nucleotide analogs to inhibit the viral RNA polymerase.
NeurologyGene Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enro
COVID-19Buprenorphine/Naloxone + BEM/RZR
Healthy Volunteer StudyClinical Trials (1)
NCT07314346Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Phase 1Drug: AT-527 + rosuvastatin
Healthy Volunteer StudyAT-527 + digoxin
Healthy Volunteers StudyAT-527 Formulation 1
Healthy Volunteer StudyClinical Trials (1)
NCT04711187Study of AT-527 in Healthy Subjects (R07496998)
Phase 1AT-752
DengueClinical Trials (1)
NCT05366439Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model
Phase 1Cohort 1 BEM + Ruzasvir
Healthy Volunteer StudyClinical Trials (1)
NCT05731843Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir
Phase 1AT-527 550 mg + midazolam
Healthy Volunteer StudyAT-527 550 mg + cyclosporine
Healthy Volunteer StudyClinical Trials (1)
NCT04849299Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998)
Phase 1Bemnifosbuvir
Healthy Volunteer StudyClinical Trials (1)
NCT06204679Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir
Phase 1AT-527
Healthy Volunteer StudyClinical Trials (1)
NCT04877769Bronchopulmonary PK of AT-527 (R07496998)
Phase 1AT-527
Healthy VolunteerClinical Trials (1)
NCT05618314Study of AT-527 in Subjects With Normal and Impaired Renal Function
Phase 1Digoxin vs Digoxin + BEM/RZR vs Digoxin + 2h BEM/RZR
Healthy Volunteer StudyClinical Trials (1)
NCT06921941Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin
Phase 1Period 1: AT-527 550 mg
Healthy Volunteer StudyAT-527
Healthy Volunteer StudyClinical Trials (1)
NCT05004415Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)
Phase 1Bemnifosbuvir
Healthy Volunteer StudyClinical Trials (1)
NCT05905497The Study of Bemnifosbuvir in Healthy Japanese Subjects
Phase 1Bemnifosbuvir
Healthy VolunteerClinical Trials (1)
NCT05724693Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function
Phase 1AT-527 fasted
Healthy Volunteer StudyClinical Trials (1)
NCT05256732Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal
Phase 1Ethinyl Estradioll/Levonorgestrel
Healthy Volunteer StudyClinical Trials (1)
NCT07272889Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Phase 1Treatment A-Bemnifosbuvir/Ruzasvir FDC administered fasting
Healthy Volunteer StudyClinical Trials (1)
NCT07007806Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir
Phase 1Cohort 1: Days 1-7 Bemnifosbuvir
Healthy Volunteer StudyClinical Trials (1)
NCT06356194Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir
Phase 1AT-752
DengueClinical Trials (1)
NCT04722627Study of AT-752 in Healthy Subjects
Phase 1Bemnifosbuvir
Healthy Volunteer StudyClinical Trials (1)
NCT05905484Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects
Phase 1Bemnifosbuvir
Healthy Volunteer StudyClinical Trials (1)
NCT06911320Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
Phase 1AT-527
Chronic Hepatitis CClinical Trials (1)
NCT03219957Study of AT-527 in Healthy and HCV-Infected Subjects
Phase 1AT-777
Hepatitis CClinical Trials (1)
NCT04309734Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects
Phase 1/2AT-527
COVID-19AT-527
Hepatitis CClinical Trials (1)
NCT04019717Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection
Phase 2Bemnifosbuvir
Chronic Hepatitis C VirusClinical Trials (1)
NCT05904470A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
Phase 2AT-527
COVID-19Clinical Trials (1)
NCT04396106Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting
Phase 2AT-752
Dengue FeverClinical Trials (1)
NCT05466240Study of AT-752 in Patients With Dengue Infection
Phase 2Bemnifosbuvir-Ruzasvir
HEPATITIS C VIRUS CHRONIC INFECTIONClinical Trials (1)
NCT06868264C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
Phase 3RO7496998
COVID-19Bemnifosbuvir-Ruzasvir
HEPATITIS C VIRUS CHRONIC INFECTIONClinical Trials (1)
NCT07037277C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Phase 3Phase 3
Clinical Trials (1)
NCT05629962SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 28 clinical trials
SEC Filings: 2 available